613 related articles for article (PubMed ID: 12542609)
41. [Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province].
Zhang BF; Cheng ML; Zhang Q; Zhao XK; Yu L; Yang J; Deng KS; Zhang LS; Wang J; Hu YX
Zhonghua Gan Zang Bing Za Zhi; 2018 Dec; 26(12):945-950. PubMed ID: 30669789
[No Abstract] [Full Text] [Related]
42. Role of serum hepatitis B virus marker quantitation to differentiate natural history phases of HBV infection.
Wang L; Zou ZQ; Wang K; Yu JG; Liu XZ
Hepatol Int; 2016 Jan; 10(1):133-8. PubMed ID: 26427997
[TBL] [Abstract][Full Text] [Related]
43. Lamivudine therapy for children with chronic hepatitis B.
Liberek A; Szaflarska-Popławska A; Korzon M; Łuczak G; Góra-Gebka M; Łoś-Rycharska E; Bako W; Czerwionka-Szaflarska M
World J Gastroenterol; 2006 Apr; 12(15):2412-6. PubMed ID: 16688835
[TBL] [Abstract][Full Text] [Related]
44. Comparison of HBV RNA and Hepatitis B Core Related Antigen With Conventional HBV Markers Among Untreated Adults With Chronic Hepatitis B in North America.
Ghany MG; King WC; Lisker-Melman M; Lok ASF; Terrault N; Janssen HLA; Khalili M; Chung RT; Lee WM; Lau DTY; Cloherty GA; Sterling RK
Hepatology; 2021 Nov; 74(5):2395-2409. PubMed ID: 34133774
[TBL] [Abstract][Full Text] [Related]
45. Sustained responses and loss of HBsAg in HBeAg-negative patients with chronic hepatitis B who stop long-term treatment with adefovir.
Hadziyannis SJ; Sevastianos V; Rapti I; Vassilopoulos D; Hadziyannis E
Gastroenterology; 2012 Sep; 143(3):629-636.e1. PubMed ID: 22659218
[TBL] [Abstract][Full Text] [Related]
46. HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients.
Peng CY; Hsieh TC; Hsieh TY; Tseng KC; Lin CL; Su TH; Tseng TC; Lin HH; Wang CC; Kao JH
J Formos Med Assoc; 2015 Apr; 114(4):308-13. PubMed ID: 24315616
[TBL] [Abstract][Full Text] [Related]
47. Hepatitis B Surface Antigen Quantification across Different Phases of Chronic Hepatitis B Virus Infection Using an Immunoradiometric Assay.
Chung KH; Kim W; Kim BG; Lee HY; Jin E; Cho Y; Seo JY; Kim HY; Jung YJ; Kim JW; Jeong JB; Lee KL
Gut Liver; 2015 Sep; 9(5):657-64. PubMed ID: 25717049
[TBL] [Abstract][Full Text] [Related]
48. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
[TBL] [Abstract][Full Text] [Related]
49. Anti-PD-1 blockade with nivolumab with and without therapeutic vaccination for virally suppressed chronic hepatitis B: A pilot study.
Gane E; Verdon DJ; Brooks AE; Gaggar A; Nguyen AH; Subramanian GM; Schwabe C; Dunbar PR
J Hepatol; 2019 Nov; 71(5):900-907. PubMed ID: 31306680
[TBL] [Abstract][Full Text] [Related]
50. Relationship between serum quantitative HBsAg and HBV DNA levels in chronic hepatitis B patients.
Yang N; Feng J; Zhou T; Li Z; Chen Z; Ming K; Liang G; Lei XX; Xu BL
J Med Virol; 2018 Jul; 90(7):1240-1245. PubMed ID: 29603789
[TBL] [Abstract][Full Text] [Related]
51. Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers.
Park H; Lee JM; Seo JH; Kim HS; Ahn SH; Kim DY; Han KH; Chon CY; Park JY
Liver Int; 2012 May; 32(5):796-802. PubMed ID: 22128792
[TBL] [Abstract][Full Text] [Related]
52. Positive association between serum apolipoprotein M levels and hepatitis B virus DNA load in HBeAg-negative chronic hepatitis B.
Shen T; Wu WM; Du WH; Wang L; He G; Tan L; Wang Z; Chen R; Hu M; Ren YP
Lipids Health Dis; 2016 Dec; 15(1):210. PubMed ID: 27927202
[TBL] [Abstract][Full Text] [Related]
53. Predictive value of interferon-gamma inducible protein 10 kD for hepatitis B e antigen clearance and hepatitis B surface antigen decline during pegylated interferon alpha therapy in chronic hepatitis B patients.
Wang Y; Zhao C; Zhang L; Yu W; Shen C; Wang W; Zhen Z; Zhou J
Antiviral Res; 2014 Mar; 103():51-9. PubMed ID: 24418572
[TBL] [Abstract][Full Text] [Related]
54. Maternal transmission risk and antibody levels against hepatitis B virus e antigen in pregnant women.
Lu LL; Chen BX; Wang J; Wang D; Ji Y; Yi HG; Chen T; Zhang Y; Petersen E; Li Q; Qu C
Int J Infect Dis; 2014 Nov; 28():41-4. PubMed ID: 25245000
[TBL] [Abstract][Full Text] [Related]
55. Baseline Level of Hepatitis B Core Antibody Predicts Spontaneous Hepatitis B e Antigen (HBeAg) Seroconversion in HBeAg-Positive Children With a Normal Alanine Aminotransferase Level.
Chen HS; Wu JF; Su TH; Chen HL; Hsu HY; Xia NS; Chen PJ; Chang MH
Hepatology; 2019 Dec; 70(6):1903-1912. PubMed ID: 31121067
[TBL] [Abstract][Full Text] [Related]
56. Interferon-alpha treatment in children and young adults with chronic hepatitis B: a long-term follow-up study in Taiwan.
Hsu HY; Tsai HY; Wu TC; Chiang CL; Ni YH; Chen PJ; Chang MH
Liver Int; 2008 Nov; 28(9):1288-97. PubMed ID: 18397229
[TBL] [Abstract][Full Text] [Related]
57. Efficacy of granulocyte-macrophage colony-stimulating factor or lamivudine combination with recombinant interferon in non-responders to interferon in hepatitis B virus-related chronic liver disease patients.
Guptan RC; Thakur V; Kazim SN; Sarin SK
J Gastroenterol Hepatol; 2002 Jul; 17(7):765-71. PubMed ID: 12121506
[TBL] [Abstract][Full Text] [Related]
58. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
Sarin SK; Kumar M; Kumar R; Kazim SN; Guptan RC; Sakhuja P; Sharma BC
Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
[TBL] [Abstract][Full Text] [Related]
59. Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance and seroconversion in hepatitis B e antigen-negative chronic infection patients: A population-based prospective cohort.
Zhu L; Zhai X; Wang Q; Jiang J; Peng H; Song C; Ge Z; Qian J; Zhou M; Zhou Y; Xu J; Liu H; Hang D; Hu Z; Shen H; Zhu F
J Viral Hepat; 2018 Dec; 25(12):1588-1598. PubMed ID: 30112835
[TBL] [Abstract][Full Text] [Related]
60. Efficacy of pre-S-containing HBV vaccine combined with lamivudine in the treatment of chronic HBV infection.
Senturk H; Tabak F; Ozaras R; Erdem L; Canbakan B; Mert A; Yurdakul I
Dig Dis Sci; 2009 Sep; 54(9):2026-30. PubMed ID: 19016327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
